Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023636
Filing Date
2017-11-14
Accepted
2017-11-13 21:57:18
Documents
66
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alpn-10q_20170930.htm 10-Q 2790063
2 EX-31.1 alpn-ex311_336.htm EX-31.1 15690
3 EX-31.2 alpn-ex312_335.htm EX-31.2 15662
4 EX-32.1 alpn-ex321_333.htm EX-32.1 8706
5 EX-32.2 alpn-ex322_334.htm EX-32.2 8699
  Complete submission text file 0001564590-17-023636.txt   6668963

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alpn-20170930.xml EX-101.INS 969865
7 XBRL TAXONOMY EXTENSION SCHEMA alpn-20170930.xsd EX-101.SCH 45751
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alpn-20170930_cal.xml EX-101.CAL 42797
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alpn-20170930_def.xml EX-101.DEF 179845
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alpn-20170930_lab.xml EX-101.LAB 338991
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alpn-20170930_pre.xml EX-101.PRE 298743
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37449 | Film No.: 171198077
SIC: 2834 Pharmaceutical Preparations